# NAUTILUS BIOTECHNOLOGY INC (NAUT)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/NAUT/

- Reporting holders: 2
- Reported value: $23.2K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Wedmont Private Capital](https://holderbook.com/funds/1904274-wedmont-private-capital/) | $18.2K | 10,000 | 0.0% | 1 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $5.0K | 3,547 | 0.0% | 1 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 2 | $23.2K |
| Q2 2026 | 94 | $112.5M |
| Q1 2026 | 83 | $211.1M |
| Q4 2025 | 67 | $114.0M |
| Q3 2025 | 65 | $48.9M |
| Q2 2025 | 69 | $43.4M |
| Q1 2025 | 87 | $54.1M |
| Q4 2024 | 87 | $107.3M |
| Q3 2024 | 81 | $183.1M |
| Q2 2024 | 75 | $149.9M |
| Q1 2024 | 70 | $188.6M |
| Q4 2023 | 76 | $191.2M |